Table of Content


1. Introduction


2. Research & Methodology


3. United States In-Vitro Diagnostics (IVD) Market


4. Market Share – United States In-Vitro Diagnostics (IVD) Analysis

4.1 By Segments
4.2 By Products
4.3 By Regions


5. Segments – United States In-Vitro Diagnostics (IVD) Market

5.1 Clinical Chemistry
5.2 Microbiology -ID/AST
5.3 Microbiology – Molecular
5.4 POC – Professional
5.5 POC - OTC Diabetes
5.6 POC – Others
5.7 Immunoassay – Infectious
5.8 Immunoassay – Others
5.9 Urinalysis
5.10 Molecular - Non Infectious
5.11 Coagulation
5.12 Histology
5.13 Hematology
5.14 Blood Testing and Typing
5.15 Flow Cytometry


6. Products – United States In-Vitro Diagnostics (IVD) Market

6.1 Services
6.2 Software
6.3 Reagents
6.4 Instruments


7. Regions – United States In-Vitro Diagnostics (IVD) Market

7.1 South
7.2 West
7.3 Midwest
7.4 North East


8. Market Dynamics

8.1 Growth Drivers

8.1.1 Growth in Chronic & Infectious Disease
8.1.2 Technological Advances
8.1.3 Aging Population

8.2 Challenges

8.2.1 Cumbersome Reimbursement Procedure
8.2.2 Shortage of Lab Technicians


9. Company Analysis

9.1 Roche Diagnostics

9.1.1 Overview
9.1.2 Initiatives & Recent Developments
9.1.3 Sales

9.2 Abbott Diagnostics

9.2.1 Overview
9.2.2 Initiatives & Recent Developments
9.2.3 Sales

9.3 Siemens Healthineers

9.3.1 Overview
9.3.2 Initiatives & Recent Developments
9.3.3 Sales

9.4 Danaher Corporation

9.4.1 Overview
9.4.2 Initiatives & Recent Developments
9.4.3 Sales

9.5 Thermo Fisher Scientific

9.5.1 Overview
9.5.2 Initiatives & Recent Developments
9.5.3 Sales

9.6 Sysmex Corporation

9.6.1 Overview
9.6.2 Initiatives & Recent Developments
9.6.3 Sales



List of Figures




Figure-01: United States IVD Market (Million US$), 2013 – 2018
Figure-02: Forecast for United States IVD Market (Million US$), 2019 – 2024
Figure-03: United States In-Vitro Diagnostics (IVD) Market Share (%) by Segments, 2013 – 2018
Figure-04: Forecast for United States In-Vitro Diagnostics (IVD) Market Share (%) by Segments, 2019 – 2024
Figure-05: United States In-Vitro Diagnostics (IVD) Market Share (%) by Products, 2013 – 2018
Figure-06: Forecast for United States In-Vitro Diagnostics (IVD) Market Share (%) by Products, 2019 – 2024
Figure-07: United States In-Vitro Diagnostics (IVD) Market Share (%) by Regions, 2019 – 2024
Figure-08: Forecast for Delivery Models - India Online Food Delivery Market Share (%) 2019 – 2023
Figure-09: United States – In-Vitro Diagnostics Market by Clinical Chemistry (Million US$), 2013 – 2018
Figure-10: United States – Forecast for In-Vitro Diagnostics Market by Clinical Chemistry (Million US$), 2019 – 2024
Figure-11: United States – In-Vitro Diagnostics Market by Microbiology -ID/AST (Million US$), 2013 – 2018
Figure-12: United States – Forecast for In-Vitro Diagnostics Market by Microbiology -ID/AST (Million US$), 2019 – 2024
Figure-13: United States – In-Vitro Diagnostics Market by Microbiology – Molecular (Million US$), 2013 – 2018
Figure-14: United States – Forecast for In-Vitro Diagnostics Market by Microbiology – Molecular (Million US$), 2019 – 2024
Figure-15: United States – In-Vitro Diagnostics Market by POC – Professional (Million US$), 2013 – 2018
Figure-16: United States – Forecast for In-Vitro Diagnostics Market by POC – Professional (Million US$), 2019 – 2024
Figure-17: United States – In-Vitro Diagnostics Market by POC - OTC Diabetes (Million US$), 2013 – 2018
Figure-18: United States – Forecast for In-Vitro Diagnostics Market by POC - OTC Diabetes (Million US$), 2019 – 2024
Figure-19: United States – In-Vitro Diagnostics Market by POC – Others (Million US$), 2013 – 2018
Figure-20: United States – Forecast for In-Vitro Diagnostics Market by POC – Others (Million US$), 2019 – 2024
Figure-21: United States – In-Vitro Diagnostics Market by Immunoassay – Infectious (Million US$), 2013 – 2018
Figure-22: United States – Forecast for In-Vitro Diagnostics Market by Immunoassay – Infectious (Million US$), 2019 – 2024
Figure-23: United States – In-Vitro Diagnostics Market by Immunoassay – Others (Million US$), 2013 – 2018
Figure-24: United States – Forecast for In-Vitro Diagnostics Market by Immunoassay – Others (Million US$), 2019 – 2024
Figure-25: United States – In-Vitro Diagnostics Market by Urinalysis (Million US$), 2013 – 2018
Figure-26: United States – Forecast for In-Vitro Diagnostics Market by Urinalysis (Million US$), 2019 – 2024
Figure-27: United States – In-Vitro Diagnostics Market by Molecular - Non Infectious (Million US$), 2013 – 2018
Figure-28: United States – Forecast for In-Vitro Diagnostics Market by Molecular - Non Infectious (Million US$), 2019 – 2024
Figure-29: United States – In-Vitro Diagnostics Market by Coagulation (Million US$), 2013 – 2018
Figure-30: United States – Forecast for In-Vitro Diagnostics Market by Coagulation (Million US$), 2019 – 2024
Figure-31: United States – In-Vitro Diagnostics Market by Histology (Million US$), 2013 – 2018
Figure-32: United States – Forecast for In-Vitro Diagnostics Market by Histology (Million US$), 2019 – 2024
Figure-33: United States – In-Vitro Diagnostics Market by Hematology (Million US$), 2013 – 2018
Figure-34: Forecast for Online Food Delivery Market By Hematology (Million US$), 2019 – 2025
Figure-35: United States – In-Vitro Diagnostics Market by Blood Testing and Typing (Million US$), 2013 – 2018
Figure-36: United States – Forecast for In-Vitro Diagnostics Market by Blood Testing and Typing (Million US$), 2019 – 2024
Figure-37: United States – In-Vitro Diagnostics Market by Flow Cytometry (Million US$), 2013 – 2018
Figure-38: United States – Forecast for In-Vitro Diagnostics Market by Flow Cytometry (Million US$), 2019 – 2024
Figure-39: United States In-Vitro Diagnostics Products Market by Services (Million US$), 2013 – 2018
Figure-40: United States – Forecast for In-Vitro Diagnostics Products Market by Services (Million US$), 2019 – 2024
Figure-41: United States In-Vitro Diagnostics Products Market by Software (Million US$), 2013 – 2018
Figure-42: United States – Forecast for In-Vitro Diagnostics Products Market by Software (Million US$), 2019 – 2024
Figure-43: United States In-Vitro Diagnostics Products Market by Reagents (Million US$), 2013 – 2018
Figure-44: United States – Forecast for In-Vitro Diagnostics Products Market by Reagents (Million US$), 2019 – 2024
Figure-45: United States In-Vitro Diagnostics Products Market by Instruments (Million US$), 2013 – 2018
Figure-46: United States – Forecast for In-Vitro Diagnostics Products Market by Instruments (Million US$), 2019 – 2024
Figure-47: United States In-Vitro Diagnostics Market by South Regions (Million US$), 2013 – 2018
Figure-48: United States – Forecast for In-Vitro Diagnostics Market by South Regions (Million US$), 2019 – 2024
Figure-49: United States In-Vitro Diagnostics Market by West Regions (Million US$), 2013 – 2018
Figure-50: United States – Forecast for In-Vitro Diagnostics Market by West Regions (Million US$), 2019 – 2024
Figure-51: United States In-Vitro Diagnostics Market by Midwest Regions (Million US$), 2013 – 2018
Figure-52: United States – Forecast for In-Vitro Diagnostics Market by Midwest Regions (Million US$), 2019 – 2024
Figure-53: United States In-Vitro Diagnostics Market by North East Regions (Million US$), 2013 – 2018
Figure-54: United States – Forecast for In-Vitro Diagnostics Market by North East Regions (Million US$), 2019 – 2024
Figure-55: Prevalence of Chronic Disease in United States (1995 - 2030)
Figure-56: Global – Population aged 65 & Over, (in Millions), 2015, 2030 & 2050
Figure-57: Roche Diagnostics – Global Sales (Million US$), 2014 – 2018
Figure-58: Roche Diagnostics – Global Sales Forecast (Million US$), 2019 – 2024
Figure-59: Abbott Diagnostics – Global Sales (Million US$), 2014 – 2018
Figure-60: Abbott Diagnostics – Global Sales Forecast (Million US$), 2019 – 2024
Figure-61: Siemens Healthineers – Global Diagnostics Sales (Million US$), 2015 – 2018
Figure-62: Siemens Healthineers – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-63: Danaher Corporation – Global Diagnostics Sales (Million US$), 2014 – 2018
Figure-64: Danaher Corporation – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-65: Thermo Fisher Scientific – Global Diagnostics Sales (Million US$), 2014 – 2018
Figure-66: Thermo Fisher Scientific – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024
Figure-67: Sysmex Corporation – Global Diagnostics Sales (Million US$), 2014 – 2018
Figure-68: Sysmex Corporation – Global Diagnostics Sales Forecast (Million US$), 2019 – 2024

 

List of Tables



N/A